论文部分内容阅读
应用凝血因子作为组织之接合剂在外科广被应用。据报告,临床上使用纤维蛋白糊作组织粘合者有:1.作出血性创口的绊创膏(特别对有出血素质者适用);2.增强缝合口及肌腱的连结;3.骨折片的固定;4.烧伤、瘘管等死腔的填充,胸膜的愈着等。纤维蛋白糊的作用机制,考虑系促进生理的创伤治愈机制而达到组织粘合作用的。本品比合成的高分子接合剂有较多的优点。本文报告纤维蛋白糊治疗术后难治性瘘管情况,由于取得较满意的效果,特报告如下。一对象以一年间术后难治性瘘管患者8例为对象,以闭锁瘘管为目的施用本剂。患者之基础疾病有:急性坏
The use of clotting factors as a cement in the surgical system is widely used. According to the report, the clinical use of fibrin paste for tissue adhesive are: 1. Hemorrhagic wounds trip adhesive (especially for those who have bleeding qualities); 2. Enhance the suture and tendon link; 3. Fractured tablets Fixed; 4 burns, fistula filling dead space, the more pleural and so on. Fibrin paste mechanism of action, to promote the physiological mechanism of wound healing to achieve tissue adhesion. This product has more advantages than synthetic polymer binder. This article reports Fibrin paste treatment of postoperative refractory fistula, due to the more satisfactory results, special report is as follows. One object to one year refractory fistula postoperative patients as the object, to block the fistula for the purpose of this agent. Patients with underlying diseases are: acute bad